Notably, long noncoding RNA SPRY4-IT1 (SPRY4 intronic transcript 1) is a transcript variant derived from the second intron of the SPRY4 gene, and it could be a good candidate biomarker for discriminating patients with cervical cancer in female population (57, 58). This evidence concerns the gene HAUS3 and cervical carcinoma.